Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Physical Ability and Cellular Senescence Elimination in HIV

NCT07144293 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT07144293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07144293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Physical Ability and Cellular Senescence Elimination in HIV
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 2
Overall status
Completed
Start date
December 4, 2025
Completion date
August 26, 2026
Enrollment
82 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

aging problems, frailty, hiv, prefrail